1h Free Analyst Time
The publisher's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Drugs In Development, 2022, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.Speak directly to the analyst to clarify any post sales queries you may have.
Prostate cancer is a form of cancer that affects men and starts off in the prostate gland. Prostate cancer usually occurs in older men. Symptoms include trouble urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips or thighs, bone pain and erectile dysfunction. Predisposing factors include age, family history and obesity. Treatment includes surgery, chemotherapy and radiation therapy.
Report Highlights
The publisher's Pharmaceutical and Healthcare latest pipeline guide Prostate Cancer - Drugs In Development, 2022, provides comprehensive information on the therapeutics under development for Prostate Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Prostate Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Prostate Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 8, 24, 203, 192, 3, 21, 350, 77 and 8 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Phase 0, Preclinical and Discovery stages comprises 13, 17, 3, 70 and 25 molecules, respectively.
Prostate Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content/sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Prostate Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Prostate Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Prostate Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Prostate Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Prostate Cancer (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Prostate Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Prostate Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Table of Contents
- Introduction
- Report Coverage
- Prostate Cancer - Overview
- Prostate Cancer - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Pipeline by Universities/Institutes
- Products under Development by Companies
- Products under Development by Universities/Institutes
- Prostate Cancer - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Prostate Cancer - Companies Involved in Therapeutics Development
- Prostate Cancer - Drug Profiles
- Prostate Cancer - Dormant Projects
- Prostate Cancer - Discontinued Products
- Prostate Cancer - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
- Coverage
- Secondary Research
- Primary Research
- Expert Panel Validation
- Contact Us
- Disclaimer
- Number of Products under Development for Prostate Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Products under Development by Companies, 2022
- Products under Development by Universities/Institutes, 2022
- Number of Products by Stage and Target, 2022
- Number of Products by Stage and Mechanism of Action, 2022
- Number of Products by Stage and Route of Administration, 2022
- Number of Products by Stage and Molecule Type, 2022
- Prostate Cancer - Dormant Projects, 2022
- Prostate Cancer - Discontinued Products, 2022
- Number of Products under Development for Prostate Cancer, 2022
- Number of Products under Development by Companies, 2022
- Number of Products under Development by Universities/Institutes, 2022
- Number of Products by Top 10 Targets, 2022
- Number of Products by Stage and Top 10 Targets, 2022
- Number of Products by Top 10 Mechanism of Actions, 2022
- Number of Products by Stage and Top 10 Mechanism of Actions, 2022
- Number of Products by Top 10 Routes of Administration, 2022
- Number of Products by Stage and Top 10 Routes of Administration, 2022
- Number of Products by Top 10 Molecule Types, 2022
- Number of Products by Stage and Top 10 Molecule Types, 2022
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3D Medicines Inc
- 4D Pharma Plc
- 4SC AG
- A28 Therapeutics Inc
- Aavocyte Inc
- Abbisko Cayman Limited
- AbbVie Inc
- Abion Inc
- Accro Bioscience Suzhou Co Ltd
- Accutar Biotechnology Inc
- Acrotech Biopharma LLC
- Actinium Pharmaceuticals Inc
- Actuate Therapeutics Inc
- ADC Therapeutics SA
- Adicet Bio Inc
- Advanced Accelerator Applications SA
- AdvanCell Isotopes Pty Ltd
- Advaxis Inc
- Advenchen Laboratories LLC
- Adze Biotechnology Inc
- Agenus Inc
- AIkido Pharma Inc
- AilseVax Ltd
- AIM ImmunoTech Inc
- Akeso Inc
- Alessa Therapeutics Inc
- Alla Chem LLC
- Allife Medical Science and Technology Co Ltd
- Alligator Bioscience AB
- Almac Discovery Ltd
- AlphaMab Co Ltd
- Alphamab Oncology
- Alpine Immune Sciences Inc
- Altay Therapeutics Inc
- Ambrx Biopharma Inc
- American Gene Technologies International Inc
- Amgen Inc
- Amphivena Therapeutics Inc
- Anagenics Ltd
- Anavex Life Sciences Corp
- Andes Biotechnologies
- AnGes Inc
- Anhorn Medicines Co Ltd
- ANP Technologies Inc
- Antapodia Therapeutics Inc
- Antares Pharma Inc
- Antev Ltd
- AntiCancer Inc
- Antikor Biopharma Ltd
- Apcure SAS
- Apexian Pharmaceuticals Inc
- Aphios Corp
- APIM Therapeutics AS
- Aprilbio Co Ltd
- Aptevo Therapeutics Inc
- Aqualung Therapeutics Corp
- Aranda Pharma Ltd
- Arch Oncology Inc
- Arcus Biosciences Inc
- Ariz Precision Medicine Inc
- Artelo Biosciences Inc
- Arvinas Inc
- Ascelia Pharma AB
- Ascentage Pharma Group Inc
- Ascentawits Pharmaceuticals Ltd
- Asieris Pharmaceuticals Co Ltd
- AskAt Inc
- Aslan Pharmaceuticals Ltd
- Astellas Pharma Inc
- AstraZeneca Plc
- Atreca Inc
- Aucentra Therapeutics Pty Ltd
- AUM Biosciences Pte Ltd
- Auransa Inc
- Aurigene Discovery Technologies Ltd
- Austhera BioSciences Inc
- Autolus Therapeutics Plc
- AvenCell Europe GmbH
- Avican Inc
- Avivia BV
- b3 bio Inc (Inactive)
- Bantam Pharmaceutical LLC
- Basilea Pharmaceutica Ltd
- Bavarian Nordic AS
- Bayer AG
- BeiGene Ltd
- Beijing Biostar Technologies Ltd
- Bellicum Pharmaceuticals Inc
- Betta Pharmaceuticals Co Ltd
- Better Life Pharmaceuticals Inc
- Bexion Pharmaceuticals LLC
- Bicycle Therapeutics Plc
- Bika Biotechnology Guanzhou Co Ltd
- Bio-Cancer Treatment International Ltd
- Bio-Path Holdings Inc
- Bio-Synectics Inc
- Bio-Thera Solutions Ltd
- BioAtla Inc
- BioCurity Pharmaceuticals Inc
- BioEclipse Therapeutics Inc
- Biohaven Pharmaceutical Holding Company Ltd
- Biokine Therapeutics Ltd
- Biolexis Therapeutics Inc
- BioNTech SE
- Biopep Solutions Inc
- Biosceptre International Ltd
- Biosplice Therapeutics Inc
- Bioven Group
- BioVie Inc
- BioXcel Therapeutics Inc
- Boehringer Ingelheim International GmbH
- Boryung Pharmaceutical Co Ltd
- BriaCell Therapeutics Corp
- Bristol-Myers Squibb Co
- Bukwang Pharmaceutical Co Ltd
- Calidi Biotherapeutics Inc
- Calidum Inc
- Calithera Biosciences Inc
- Camurus AB
- Can-Fite BioPharma Ltd
- Cancer Targeted Technology LLC
- Candel Therapeutics Inc
- Canget BioTekpharma LLC
- Cardiff Oncology Inc
- Carina Biotech Pty Ltd
- Carrick Therapeutics Ltd
- CAS-Lamvac Biotech Co Ltd
- Celcuity Inc
- Cellbion Co Ltd
- CellCentric Ltd
- Celldex Therapeutics Inc
- Cellid Co Ltd
- Cello Therapeutics Inc
- Cells for Cells SA
- CellVax Therapeutics Inc
- Celprogen Inc
- Celtek Bioscience LLC
- ChemRegen Inc
- Chia Tai Tianqing Pharmaceutical Group Co Ltd
- Chimeric Therapeutics Ltd
- Chimerix Inc
- Chong Kun Dang Pharmaceutical Corporation
- Clarity Pharmaceuticals Ltd
- Cloaked Therapeutics LLC
- Clovis Oncology Inc
- CMG Pharmaceutical Co Ltd
- CNBX Pharmaceuticals Inc
- Codagenix Inc
- CohBar Inc
- Coherent Biopharma
- Context Therapeutics Inc
- Convalife
- Convergent Therapeutics Inc
- Corcept Therapeutics Inc
- Corvus Pharmaceuticals Inc
- Cosmo Pharmaceuticals NV
- Cothera Bioscience Pty Ltd
- Crescendo Biologics Ltd
- CSPC Pharmaceutical Group Ltd
- CStone Pharmaceuticals Co Ltd
- Cue Biopharma Inc
- Curadis GmbH
- Curasight
- CureLab Oncology Inc
- CureMeta LLC
- Curigin Co Ltd
- Curium Midco Sarl
- Curve Therapeutics Ltd
- Cyclacel Pharmaceuticals Inc
- CytoImmune Therapeutics Inc
- CytomX Therapeutics Inc
- CZ BioMed Corp
- Da Zen Theranostics Inc
- Daewon Pharmaceutical Co Ltd
- Daewoong Pharmaceutical Co Ltd
- Daiichi Sankyo Co Ltd
- DEKK-TEC Inc
- DevaCell Inc
- DexTech Medical AB
- Diakonos Research Ltd
- Disulfican Ltd
- Divide and Conquer Ltd
- DNJ Pharma Inc
- Dracen Pharmaceuticals Inc
- Duet Therapeutics Inc
- Duo Oncology Inc
- Ectin Research AB
- Eisai Co Ltd
- Elevation Oncology Inc
- Eli Lilly and Co
- Ellipses Pharma Ltd
- Emtora Biosciences
- Enara Bio Ltd
- Enceladus Pharmaceuticals BV
- Endoceutics Inc
- Ennaid Therapeutics LLC
- EntreChem SL
- EOS Biosciences Inc
- EpiAxis Therapeutics Pty Ltd
- EpicentRx Inc
- Epigene Therapeutics Inc
- EpimAb Biotherapeutics Inc
- Epizyme Inc
- Esanex Inc
- ESSA Pharma Inc
- EstryX Pharma Ltd
- Etern BioPharma Co Ltd
- Eternity Bioscience Inc
- Eurofarma Laboratorios SA
- Evgen Pharma Plc
- Exelixis Inc
- ExonanoRNA LLC
- F. Hoffmann-La Roche Ltd
- Fate Therapeutics Inc
- Felicitex Therapeutics Inc
- Fog Pharmaceuticals Inc
- For-Robin Inc
- Foresee Pharmaceuticals Co Ltd
- Forma Therapeutics Inc
- Fortis Therapeutics Inc
- Fujifilm Holdings Corp
- Fusion Pharmaceuticals Inc
- Future Medicine Co Ltd
- FutureChem Co Ltd
- G1 Therapeutics Inc
- Galectin Therapeutics Inc
- GemVax & KAEL Co Ltd
- Genelux Corp
- Genentech USA Inc
- Geneos Therapeutics Inc
- Genetic Immunity Inc
- GenFleet Therapeutics (Shanghai) Inc
- GenKyoTex SA
- Genmab AS
- GeoVax Labs Inc
- Gilead Sciences Inc
- Glactone Pharma AB
- GLG Pharma SA
- Glycomantra Inc
- GlycoMimetics Inc
- GlycoNex Inc
- GlyTech Inc
- GlyTherix Ltd
- GO Therapeutics Inc
- Greenfire Bio LLC
- GSK plc
- GT Biopharma Inc
- Guangzhou Doublle Bioproduct Inc
- HaimBio Ltd
- Hanmi Pharmaceuticals Co Ltd
- Harbin Gloria Pharmaceuticals Co Ltd
- Harpoon Therapeutics Inc
- HCW Biologics Inc
- Health Ever Bio-Tech Co Ltd
- Heidelberg Pharma AG
- Helixmith Co Ltd
- Hinova Pharmaceuticals Co Ltd
- Hookipa Pharma Inc
- HOX Therapeutics Ltd
- Hualan Biological Engineering Inc
- Hummingbird Bioscience Pte Ltd
- Hutchison MediPharma Ltd
- IC-MedTech Inc
- Idience Co Ltd
- Ildong Pharmaceutical Co Ltd
- ImaginAb Inc
- ImCheck Therapeutics SAS
- Immix BioPharma Inc
- Immune Biosolutions Inc
- Immune Pharmaceuticals Inc
- Immunic Inc
- ImmunityBio Inc
- Immunogenesis Inc
- ImmunSYS Inc
- IMPACT Therapeutics Inc
- Incyte Corp
- Infinity Pharmaceuticals Inc
- Inmune Bio Inc
- InnoCare Pharma Ltd
- Innocrin Pharmaceuticals Inc
- Innovative Cellular Therapeutics Co Ltd
- Innovimmune Biotherapeutics Inc
- Inovio Pharmaceuticals Inc
- Inserm Transfert SA
- Io Therapeutics Inc
- Ionis Pharmaceuticals Inc
- Isoprene Pharmaceuticals Inc
- iTeos Therapeutics Inc
- ITM Isotope Technologies Munich SE
- Jacobio Pharmaceuticals Group Co Ltd
- Janux Therapeutics Inc
- Jiangsu Hengrui Medicine Co Ltd
- Jiangsu ProteLight Pharmaceutical & Biotechnology Co Ltd
- Jina Pharmaceuticals Inc
- Johnson & Johnson
- JSK Therapeutics Inc
- Jubilant Therapeutics Inc
- JW Pharmaceutical Corp
- Jyant Technologies Inc
- Kalos Therapeutics Inc
- Kangpu Biopharmaceuticals Ltd
- Karyopharm Therapeutics Inc
- Kezar Life Sciences Inc
- Kinnate Biopharma Inc
- Kintor Pharmaceutical Ltd
- Komipharm International Co Ltd
- KOP Therapeutics Corp
- Kringle Pharma Inc
- Kronos Bio Inc
- KYAN Therapeutics Inc
- Laekna Therapeutics Shanghai Co Ltd
- Lantern Pharma Inc
- LATITUDE Pharmaceuticals Inc
- LAVA Therapeutics NV
- Leap Therapeutics Inc
- Lidds AB
- Liminal BioSciences Inc
- Lipo-Immuno Tech LLC
- LipoSeuticals Inc
- Livzon Pharmaceutical Group Co Ltd
- Luminus Biosciences Inc
- Luye Pharma Group Ltd
- Lycotec Ltd
- Lyvgen Biopharma Ltd
- MacroGenics Inc
- Madison Vaccines Inc
- MAIA Biotechnology Inc
- Marengo Therapeutics Inc
- Matrix Biomed Inc
- MaxiVAX SA
- Mayne Pharma Group Ltd
- Meabco AS
- Med Discovery SA
- MedAnnex Ltd
- MediaPharma SRL
- Medigen Inc
- MediGene AG
- MedinCell SA
- Mediolanum farmaceutici SpA
- Medolife Rx Inc
- MedPacto Inc
- Merck & Co Inc
- Merck KGaA
- Merus NV
- MesaGen LLC
- Metacurum Biotech AB
- MetasTx LLC
- MetCure Therapeutics LLC
- MGC Pharmaceuticals Ltd
- Midissia Therapeutics Inc
- Minerva Biotechnologies Corp
- MiNK Therapeutics Inc
- Mithra Pharmaceuticals SA
- Modra Pharmaceuticals BV
- Molecular Partners AG
- Molecular Templates Inc
- Momotaro-Gene Inc
- MorphoSys AG
- Multitude therapeutics Inc
- Mustang Bio Inc
- Myrio Therapeutics Pty Ltd
- Nanjing Sanhome Pharmaceutical Co Ltd
- Nanocan Therapeutics Corp
- Nanogenics Ltd
- Nanology LLC
- National Medical Research Center of Radiology
- Natsar Pharmaceuticals Inc
- NeoTX Therapeutics Ltd
- Nerviano Medical Sciences SRL
- NewBay Medical Technology Co Ltd
- NewG Lab Pharma Inc
- NextCure Inc
- NGM Biopharmaceuticals Inc
- Novartis AG
- Novelogics Biotechnology Inc
- Noxopharm Ltd
- Nuage Therapeutics SL
- NucleoBio Inc
- NuGenerex Immuno-Oncology Inc
- Nurix Therapeutics Inc
- Nutshell Therapeutics Inc
- Nuvation Bio Inc
- Nymox Pharmaceutical Corp
- Ohana Vaccine LLC
- Omeros Corp
- Ona Therapeutics SL
- OncoFusion Therapeutics Inc
- Oncomatryx Biopharma SL
- Onconic Therapeutics Co Ltd
- OncoOne Research & Development GmbH
- OncoQuest Inc
- Oncorus Inc
- OncoTartis Inc
- Oncotelic Therapeutics Inc
- OncoTherapy Science Inc
- OncoTherics Ltd
- Oncternal Therapeutics
- Oneness Biotech Co Ltd
- Ono Pharmaceutical Co Ltd
- Onxeo SA
- OPKO Health Inc
- Orano Med LLC
- ORCA Therapeutics BV
- ORIC Pharmaceuticals Inc
- Orion Corp
- Otsuka Pharmaceutical Co Ltd
- Oxford Vacmedix UK Ltd
- Pact Pharma Inc
- Pahan Therapeutics
- Palisades Therapeutics
- Panacela Labs Inc
- Panbela Therapeutics Inc
- Pandomedx Inc
- Pantarhei Oncology BV
- Parabon NanoLabs Inc
- PDS Biotechnology Corp
- Pellficure Pharmaceuticals Inc
- PendreaBio Inc
- Penzymes LLC
- PepVax Inc
- Pfizer Inc
- Phanes Therapeutics Inc
- Pharma Mar SA
- Pharmadrug Inc
- Pharmicell Co Ltd
- pHion Therapeutics Ltd
- Phoenix Molecular Designs
- Pimera Inc
- Plexium Inc
- Plus Therapeutics Inc
- POINT Biopharma Global Inc
- Polaris Pharmaceuticals Inc
- Polyplus-Transfection SA
- Portage Biotech Inc
- Poseida Therapeutics Inc
- Potenza Therapeutics Inc
- Praesidia Biotherapeutics Inc
- Precision Molecular Inc
- Prelude Therapeutics Inc
- Primary Peptides Inc
- PRISM Pharma Co Ltd
- ProDa BioTech LLC
- Progenics Pharmaceuticals Inc
- Promontory Therapeutics Inc
- Propanc Biopharma Inc
- Propella Therapeutics Inc
- Proteovant Therapeutics Inc
- Protheragen Inc
- Puma Biotechnology Inc
- Purple Biotech Ltd
- QED Therapeutics Inc
- Qilu Pharmaceutical Co Ltd
- Qu Biologics Inc
- Quadriga BioSciences Inc
- Qualigen Therapeutics Inc
- Que Oncology Inc
- QurCan Therapeutics Inc
- Qurient Co Ltd
- Qwixel Therapeutics LLC
- Radiomedix Inc
- Radiopharm Theranostics Ltd
- Rasayani Biologics Pvt Ltd
- Ratio Therapeutics Inc
- Recordati SpA
- RedHill Biopharma Ltd
- Regeneron Pharmaceuticals Inc
- Reglagene Holding Inc
- Regulaxis SAS
- Replicate Bioscience Inc
- Res Nova Bio Inc
- Revere Pharmaceuticals Inc
- RheinCell Therapeutics GmbH
- Rhizen Pharmaceuticals SA
- Riptide Bioscience Inc
- Roivant Sciences Ltd
- RS Research
- Rubicon Biotechnology Inc
- Ryvu Therapeutics SA
- Sagimet Biosciences Inc
- Salarius Pharmaceuticals Inc
- Samyang Biopharmaceuticals Corp
- San Rocco Therapeutics LLC
- Sanofi
- Sapience Therapeutics Inc
- Sathgen Biotech
- Seagen Inc
- Seagull BioSolutions Pvt Ltd
- Semorex Inc
- Senex Biotechnology
- Senhwa Biosciences Inc
- Serene LLC
- Seven and Eight Biopharmaceuticals Corp
- Shanghai Bioray Laboratory Inc
- Shanghai De Novo Pharmatech Co Ltd
- Shanghai Escugen Biotechnology Co Ltd
- Shanghai Fosun Pharmaceutical (Group) Co Ltd
- Shanghai Haihe Biopharma Co Ltd
- Shanghai Henlius Biotech Inc
- Shanghai Huilun Life Science & Technology Co Ltd
- Shanghai Humantech Biotechnology Co Ltd
- Shanghai YaKe Biotechnology Co Ltd
- Shanghai Yihao Biotechnology Co Ltd
- Shanghai Yuyao Biotechnology Ltd
- Shenogen Pharma Group Ltd
- Shijiazhuang No. 4 Pharmaceutical Co Ltd
- Sichuan Huiyang Life Science and Technology Corp
- Siege Pharmaceuticals Inc
- SignPath Pharma Inc
- Silenseed Ltd
- Sillajen Biotherapeutics
- Singh Biotechnology LLC
- Sino Biopharmaceutical Ltd
- SiNOPSEE Therapeutics Pte Ltd
- Siragen Pharmaceuticals Inc
- Sisu Pharma Inc
- SL VaxiGen Inc
- Smerud Medical Research International AS
- SN BioScience
- Socium Inc
- Socium Therapeutics Inc
- Sonnet BioTherapeutics Holdings Inc
- Soricimed Biopharma Inc
- Sorrento Therapeutics Inc
- Sosei Group Corp
- SOTIO Biotech AS
- Spexis AG
- Splash Pharmaceuticals Inc
- Starpharma Holdings Ltd
- Stcube Inc
- Sumitomo Dainippon Pharma Oncology, Inc
- Suzhou Innovative Biomaterials & Pharmaceutics Co Ltd
- Suzhou Medilink Therapeutics Ltd
- Suzhou Ribo Life Sciences Co Ltd
- Syncromune Inc
- SynDevRx Inc
- Syntrix Pharmaceuticals
- Tactical Therapeutics Inc
- TAE Life Sciences LLC
- Taiho Oncology Inc
- Taiho Pharmaceutical Co Ltd
- Takeda Pharmaceutical Co Ltd
- Takis Srl
- Tango Therapeutics Inc
- TargaGenix Inc
- TargImmune Therapeutics AG
- Targovax ASA
- Tavanta Therapeutics Inc
- Telix Pharmaceuticals Ltd
- Tempest Therapeutics Inc
- Teon Therapeutics Inc
- Tetranov International Inc
- Teva Pharmaceutical Industries Ltd
- Tevogen Bio Inc
- The National Institute for Biotechnology in the Negev Ltd
- Theranano LLC
- TheraTarget Inc
- Theratechnologies Inc
- Theravectys SA
- Thryv Therapeutics Inc
- TiumBio Co Ltd
- Tiziana Life Sciences Plc
- Tmunity Therapeutics Inc
- TOLREMO Therapeutics AG
- TRACON Pharmaceuticals Inc
- Transcenta Holding Ltd
- TransThera Sciences (Nanjing) Inc
- Treadwell Therapeutics Inc
- TREAT U SA
- TRIM-edicine Inc
- Turnstone Biologics Inc
- TVAX Biomedical Inc
- Twinpigbiolab Co Ltd
- Tyg Oncology Ltd
- Tyme Inc
- UbiVac Inc
- UCB SA
- Ultimovacs AS
- Up Therapeutics Inc
- UroGen Pharma Ltd
- UTC Therapeutics Inc
- Vaccitech Plc
- ValiRx Plc
- Valiseek Ltd
- Vasgen Ltd
- VasGene Therapeutics Inc
- Vault Pharma Inc
- VaxCell Biotherapeutics Co Ltd
- Vaxon Biotech
- Venus Remedies Ltd
- Verastem Inc
- Veru Inc
- Vincerx Pharma Inc
- Virocure Inc
- Vitanova Biomedical Inc
- Vittail Ltd
- Vivesto AB
- VLP Therapeutics LLC
- VM Discovery Inc
- Vortex Biotechnology Corp
- Walking Fish Therapeutics Inc
- Werewolf Therapeutics Inc
- WntResearch AB
- Wuxi Jesse Pharmaceutical Co Ltd
- Xbrane Biopharma AB
- XEME BioPharma Inc
- Xencor Inc
- Xenimmune
- Xiangxue Life Sciences
- Xiconic Pharmaceuticals LLC
- XinThera Inc
- Y-mAbs Therapeutics Inc
- Yisheng Biopharma Co Ltd
- Zenith Epigenetics Ltd
- Zenopharm LLC
- Zhejiang Conba Pharmaceutical Co Ltd
- Zhejiang Hisun Pharmaceutical Co Ltd
- Zhengda Tianqing Pharmaceutical Group Co Ltd
- Zhuhai Beihai Biotech Co Ltd
- Zumutor Biologics Inc
- Zy Therapeutics Inc
